Transcode Therapeutics所有資訊

Transcode Therapeutics | PRE 14A：並購重組委托聲明

10/15 17:25 (美東)

Transcode Therapeutics | 8-K：重大事件

09/27 16:05 (美東)

Transcode Therapeutics | 8-K：重大事件

08/28 06:09 (美東)

Transcode Therapeutics | 8-K：重大事件

08/16 17:08 (美東)

Transcode Therapeutics | 10-Q：2024財年二季報

08/14 16:51 (美東)

Transcode Therapeutics | SC 13G：超過5%持股股東披露文件-3i, LP(9.9%),3i Management LLC(9.9%)等

07/26 16:09 (美東)

Transcode Therapeutics | 8-K：重大事件

07/24 09:04 (美東)

Transcode Therapeutics | 424B5：募資說明書

07/24 08:19 (美東)

Transcode Therapeutics | 424B5：募資說明書

07/22 16:13 (美東)

Transcode Therapeutics | SC 13D：超過5%持股股東披露文件-Thomas A. Fitzgerald(5.5%)

06/21 16:09 (美東)

Transcode Therapeutics | 4：持股變動聲明-高管 Fitzgerald Thomas A

06/18 16:22 (美東)

Transcode Therapeutics | 4：持股變動聲明-董事 Manting Erik

06/18 16:22 (美東)

Transcode Therapeutics | 4：持股變動聲明-董事 Marquet Magda

06/18 16:21 (美東)

Transcode Therapeutics | 4：持股變動聲明-董事 Calais Philippe

06/18 16:20 (美東)

Transcode Therapeutics | 8-K/A：重大事件(修正)

06/14 08:04 (美東)

Transcode Therapeutics | 8-K：重大事件

06/13 17:09 (美東)

Transcode Therapeutics | DEFA14A：其他

06/10 08:48 (美東)

Transcode Therapeutics | 8-K：重大事件

06/07 16:03 (美東)

Transcode Therapeutics | DEFA14A：其他

06/07 16:03 (美東)

Transcode Therapeutics | DEFR14A：修正後委託徵集材料

05/20 16:01 (美東)